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Abstract 
The leukocyte adhesion molecule DNAM-1 (CD226) is a member of the 
immunoglobulin superfamily and constitutively expressed on the majority of CD4+ 
and CD8+ T lymphocytes, natural killer (NK) cells, monocytes/macrophages and a 
subset of B lymphocytes.  The poliovirus receptor (PVR; CD155) and its family 
member nectin 2 (CD112) have recently been identified as the ligands for DNAM-1.  
Interaction of DNAM-1 with the ligands induces NK cell- and CD8+ T cell-mediated 
cytotoxicity and cytokine secretion.  However, in vivo function of the receptor-ligand 
interaction has remained unclear.  Here, we identified murine DNAM-1 and PVR 
homologues that physically and functionally bind each other.  We demonstrated 
that ligand binding of murine DNAM-1 induced a costimulatory signal in 
antigen-specific CD8+ T cells.  These results should provide a useful animal model 
to explore a role of DNAM-1 in immune responses in vivo.  
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Introduction 
DNAM-1 (CD226) is an adhesion molecule that is a member of immunoglobulin 
superfamily containing two Ig-like domains of the V-set and is encoded by a gene on 
human chromosome 18q22.3 [1, 2].  DNAM-1 is a ~65 kDa glycoprotein expressed 
on the majority of NK cells, T cells, monocytes and platelets and a subset of B 
lymphocytes [2-5].  The monoclonal antibody (mAb) against DNAM-1 inhibited 
antigen-specific CTL- and NK cell-mediated cytolysis of some, but not all, tumor 
targets in vitro, suggesting that DNAM-1 is involved in cytotoxicity against certain 
tumor cells expressing the DNAM-1 ligand.  We and others have recently identified 
the poliovirus receptor (PVR) CD155 and its family member CD112 (PVR-related 
family-2 (PRR-2), also called as nectin-2) as the ligands for human DNAM-1 [6, 7].  
Interaction of DNAM-1 with DNAM-1 ligands CD155 and CD112 induces intercellular 
adhesion, infiltration and cell signaling, resulting in a variety of cellular responses 
including innate and adaptive immunities in vitro [8].  Recently, gibbon and monkey 
homologues of DNAM-1 have been identified [9].  However, because murine 
DNAM-1 has not yet been identified, in vivo analysis of DNAM-1 function has been 
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difficult to be performed. 
In the present study, we identified the murine DNAM-1 and its ligands and 
investigated their molecular and functional characteristics.      
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Materials and Methods 
 
Cells and mice 
C57BL/6 mice were purchased from Charles River Japan and were bred 
and housed under specific pathogen-free conditions.  B3Z, a murine CD8+ T cell 
hybridoma specific for the dominant H-2Kb MHC class I/ovalbumin peptide 
(SIINFEKL; OVA257–264), were generously provided from Nilabh Shastri (UC Berkley, 
CA).  BW5147, RMA, RMA-S and EL-4 are murine T lymphoma cell lines.  Ba/F3, 
SP2/0 and P815 are murine pro-B, myeloma and mastocytoma cell lines, 
respectively.   
 
Antibodies  
Anti-mouse DNAM-1 (TX-42) mAb was generated in our laboratory by 
standard methods.  Control rat and mouse IgGs, anti-mouse CD3, CD4, CD8, 
CD49b (DX5), CD45R (B220), CD11b (Mac1) and Ly6G (Gr-1) were purchased from 
BD Biosciences (San Jose, CA).  Anti-human IgG was purchased from 
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ImmunoTech (Marseille, France).   
 
Expression of the Fc fusion protein 
Mouse DNAM-1-Fc fusion protein was generated with chimeric cDNA of the 
entire extracellular domain of DNAM-1 with the human IgG1 Fc, as described [6]. 
 
Establishment of RMA transfectants with DNAM-1 ligands 
Mouse CD112α, CD112δ and CD155 cDNAs tagged with the flag at the 
N-terminus were subcloned into the retrovirus vector pMX, with cloning sites of Eco 
RI (5’)/Sal I (3’), Eco RI (5’)/Sal I (3’), and Eco RI (5’)/Sal I (3’), respectively.  RMA 
cells stably expressing Flag-tagged mock control, mouse CD112α, CDδ and 
CD155 were prepared by retroviral gene-transduction system using the Plat-E 
packaging cell line (provided from Toshio Kitamura, University of Tokyo, Japan).  
 
Costimulation assay 
1 x 105 of CD112δ, CD155 or mock-transduced RMA were pulsed with 
  Tahara-Hanaoka et al 
 7 
various doses of the OVA peptides (SIINFEKL) for 2 hours and co-cultured with 1 x 
105 of B3Z CD8+ T cells whose TCR is specific to the OVA peptide for 24 hours in 
the presence of control Ig (10 ug/ml) or anti-mDNAM-1 mAb (10 ug/ml).  The IL-2 
production in the supernatant was determined by ELISA (eBioscience, San Diego, 
CA).  
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Results and Discussion 
Identification of the murine CD226  
To identify the mouse DNAM-1 (mDNAM-1), we searched a mouse 
genomic database and identified it on the chromosome 18, syntenic region of human 
chromosome 18q22.3 at which human DNAM-1 gene is located [1].  We amplified a 
999-bp cDNA clone from a splenocyte cDNA library by PCR, using primers designed 
based on the DNA sequence of the exons of the mDNAM-1 gene.  The cDNA 
contained an open reading frame encoding a type I transmembrane protein with an 
18-amino acid (aa) leader sequence, a 233-aa extracellular domain, a 23-aa 
transmembrane domain and a 59-aa cytoplasmic region (Fig 1A).  The predicted 
amino acid sequence of the mDNAM-1 demonstrated 53% aa homology with human 
DNAM-1.  The extracellular domain contains 7 potential N-glycosylated sites, most 
of which are conserved also in the human DNAM-1.  The tyrosine at residue 322 
and the serine at residue 329 of the human DNAM-1 cytoplasmic region, both of 
which are phosphorylated and play important roles in DNAM-1-mediated signaling 
for lymphocytes activation [10] [11] and intercellular adhesion [2] [4], are also 
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conserved in the mDNAM-1, suggesting that DNAM-1 function is conserved in both 
human and murine.   
 
Identification of the murine CD155 
We and others have recently reported that the human poliovirus receptor 
related (PRR) family members CD155 (poliovirus receptor; PVR) and CD112 
(nectin-2/PRR-2) are the ligands for human DNAM-1 [6] [7].  While the CD112 gene 
was reported also in mouse [12, 13], CD155 that was originally identified as a 
poliovirus receptor has been identified only in human [14].  Since mice are resistant 
to the poliovirus infection, the murine homologue of CD155 has not been believed to 
be present.  However, we found in a database that the predicted aa sequence of 
Tage4 (also known to be Taa-1 (Tumor associated antigen-1)) showed 43% 
homology with human CD155 and contained three immunoglobulin-like domains in 
the extracellular portion that are conserved in human CD155 [15, 16].  The Tage4 
gene is located at mouse chromosome 7, syntenic region of human chromosome 19, 
at which human CD155 is located, suggesting that Tage4/TAA-1 may be the mouse 
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homologue of CD155 (mCD155).  
 
mDNAM-1 binds to mCD112 and mCD155 
To examine whether mCD112 and mCD155 are functional ligands for 
mDNAM-1, we generated a soluble protein consisting of the extracellular domain of 
mDNAM-1 fused to the Fc portion of human IgG (mDNAM-1-Fc).  We also 
established the RMA transfectants stably expressing mCD112α, mCD112δ or Tage4 
(RMA-CD112α, RMA-CD112δ and RMA-CD155, respectively).  These transfectants 
were stained with the mDNAM-1-Fc and analyzed by flow cytometry.  As 
demonstrated in Fig 1B, the mDNAM-1-Fc specifically bound to the transfectants 
expressing mCD112 or Tage4, but not to mock-transduced RMA (RMA-mock), 
formally demonstrating that mCD112 and CD155 are ligands for mDNAM-1 and 
Tage4 is the mouse homologue of CD155.  
Colonna and colleagues have recently identified the T cell-activated 
increased late expression (Tactile) (also called as CD96) as another receptor ligand 
for human CD155 [17], although CD96 does not bind to CD112 (our unpublished 
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observation).  CD96 is expressed on activated T cells and NK cells [18] and 
mediates NK cell adhesion and triggering of effector function [17].  It is unclear at 
present whether the mouse homologue of CD96, though it has not yet been 
identified, also a receptor for mouse CD155.  
 
Expression of mDNAM-1 and its ligands 
 We generated a mAb against mDNAM-1 and examined the expression of 
mDNAM-1 on splenocytes by flow cytometry.  DNAM-1 was expressed on the 
majority of both splenic CD8+ and CD4+ T cells in mice (Fig 2A), consistent with its 
expression pattern in human [1].  CD8+ T cells appeared to express higher amount 
of mDNAM-1 than CD4+ T cells.  While DNAM-1 is also expressed on most 
peripheral NK cells and macrophages in human, only a subset of splenic NK cells 
and macrophages expressed DNAM-1 in mice (Figs 2A).   
We also examined the expression of mDNAM-1 ligands on various cell 
lines.  The mDNAM-1-Fc specifically bound to T cell leukemia cell lines BW5147 
and EL-4, a myeloma cell line SP2/0 and a mastocytoma cell line P815, but not to a 
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pro-B cell line Ba/F3 and a T cell lymphoma RMA and its major histocompatibility 
complex (MHC) class I-deficient variant cell line RMA-S (Fig 2B), suggesting the 
existence of mDNAM-1 ligands expression on BW5147, EL-4 and P815 and the 
absence on Ba/F3, RMA and RAM-S.  We also observed that the fusion protein did 
not show detectable level of binding to spleen cells from C57BL/6 or BALB/c mice 
(data not shown), suggesting that resting spleen cells do not express mDNAM-1 
ligands.  
 
DNAM-1 mediates a costimulatory signal in antigen-specific CD8+ T cells 
 Because CD8+ T cells expressed a significant amount of mDNAM-1 on cell 
surface, we investigated a role of DNAM-1 in antigen-specific CD8+ T cells.  CD8+ 
T cell hybridoma with the OVA peptide (OVA257–264)-specific TCR were co-cultured 
with RMA-mock, RMA-CD112δ or RMA-CD155 that had been pre-pulsed with 
various doses of the OVA-peptide.  As demonstrated in Fig 3, IL-2 production from 
the CD8+ T cells increased in response to the peptide-antigen presented on 
RMA-mock in a dose dependent manner.  However, expression of CD112 or CD155 
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on RMA significantly increased IL-2 production.  In contrast, blockade of DNAM-1 
interaction with the ligands CD112 or CD155 with anti-DNAM-1 mAb completely 
canceled the increase in IL-2 production from the CD8+ T cells.  These results 
suggested that ligand binding of DNAM-1 induced a costimulatory signal in 
antigen-specific CD8+ T cells. 
 In conclusion, we have reported mDNAM-1 and its ligands that physically 
and functionally bind each other.  The receptor–ligands interactions mediated a 
co-stimulatory signal in antigen-specific T cells.  These results should provide us a 
useful animal model for analysis of in vivo role of DNAM-1 in immune responses. 
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Figure Legends 
 
Figure 1. Characterization of mouse DNAM-1 
(A) The mDNAM-1 demonstrated 53% amino acid homology with human DNAM-1.  
Identical amino acids are indicated by asterisk. The leader sequences and the 
transmembrane region are underlined and boxed, respectively.  Potential 
N-linked glycosylation sites in the extracellular domain are circled.  The 
tyrosine and serine residues at 322 and 329 (bold) in the cytoplasmic region of 
human DNAM-1 are conserved in mouse.  The cDNA sequence data of mouse 
DNAM-1 is available from EMBL, GenBank and DDBJ at accession number 
AB195429.  
(B) RMA cells that lack DNAM-1 ligand expression were retrovirally transduced with 
mCD112α, mCD112δ or mCD155 and stained with mCD226-Fc fusion protein 
(solid line) or control human IgG1 (dotted line), followed by FITC-conjugated 
anti-human IgG, and analyzed by flow cytometry. 
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Figure 2.  Expression of DNAM-1 on splenocytes in mice 
(A) Spleen cells from C57BL/6 mice were stained with FITC-conjugated anti-CD3, 
biotin-conjugated anti-DNAM-1 and either PE-labeled antibodies against lineage 
markers indicated (A, B, C), followed by APC-conjugated streptavidin.  Spleen 
cells were also stained with PE-conjugated anti-CD11c, FITC-conjugated 
anti-CD8 and biotin-conjugated anti-DNAM-1, followed by APC-conjugated 
streptavidin (D).  Numbers indicate the percentage of each fraction.  
(B) Tumor cell lines were stained with mCD226-Fc (solid line) or control human 
IgG1(dotted line), followed by FITC-conjugated anti-human IgG, and analyzed by 
flow cytometry. 
 
 
Figure 3. DNAM-1 mediates a costimulatory signal in antigen-specific CD8+ T 
cells  
  1 x 105 mock-transduced RMA tumor cells or CD112-, or 
CD155-transduced RMA tumor cells were pulsed with OVA peptides at various 
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concentrations indicated for 2 hours and then co-cultured with 1 x 105 
OVA-peptide-specific CD8+ T cell hybridoma (B3Z) in the presence of control Ig or 
anti-mDNAM-1 mAb.  IL-2 productions from the T cells were determined by ELISA. 
 
 
 
 
